1. We've updated our Bayesian meta-analysis of the effectiveness of #ivermectin in treating #COVID19 to take acount of concerns about veracity of certain studies (notably Elgazzar). Summary with link to full paper: probabilityandlaw.blogspot.com/2021/07/iverme…
2. It evaluates sensitivity of the conclusions to any single study by removing one study at a time. In the worst cas (Elgazzar removed) results remain robust, for both severe and mild/moderate Covid-19. Ivermectin reduces mortality. Full paper: dx.doi.org/10.13140/RG.2.…
3. (should be "worst case" not "worst cas"!!) So it supports the conclusions of @PierreKory @BIRDGroupUK etc
4. Also, as with previous papers that 'challenge' the main stream narrative, the paper was not accepted on @medrxivpreprint Explanation is curious given the whole point of a preprint server is to publish unreviewed work (& they normally automatically accept anything in scope): 
• • •
Missing some Tweet in this thread? You can try to
force a refresh
